Dr. Jason Michael Glover was born in Columbus Ohio. During his fellowship at Oregon Health Scences University, while there he worked in the lab of Brian Druker MD, who helped pioneer the drug Gleevec for the cancer CML. He is very interested in developing personalized medicine. Dr Glover has published a number of papers and presented at many national conferences. He is currently a member of: The American Society of Pediatric of Hematology/Oncology, The American Socety of Clinical Oncology, and the Children’s Oncology Group. He and the program at Randall Children’s Hospital are proud and excited to be the only program in the Pacific Northwest to offer novel treatments through Beat Childhood Cancer
His areas of expertise include Solid Tumors (including Neuroblastoma, Osteosarcoma, Ewings Sarcoma and other rare solid tumors), New and Experimental Therapeutics, Leukemia, and Sickle Cell Disease. Personal Interests include hiking, cycling, participating in triathlons, and surfing very badly. Dr. Glover also enjoys reading, and most importantly spending time with his family.
A Summary of the Osteosarcoma Banking Efforts: A Report from the Children’s Oncology Group and the QuadW Foundation Pediatric Blood and Cancer. Jason Glover, Don Barkauskas2 Timothy M. Fan, Richard Gorlick, Chand Khanna, and the COG Osteosarcoma Biology Group
In vitro sensitivity to Dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre B Acute Lymphoblastic Leukemia. Pediatric Blood and Cancer. Jason Glover MD, Marc Loriaux MD PhD, Jeff W. Tyner PhD, Brian J. Druker MD, & Bill H. Chang MD PhD
An Adaptive Src-PDGFRA-Raf Axis in Rhabdomyosarcoma. Biochemical Biophysical Research Communications. Jinu Abraham, Ying Xuan Chua, Jason M. Glover, Jeffrey W. Tyner, Marc M. Loriaux, Aoife Kilcoyne, Francis J. Giles, Laura D. Nelon, Jennifer S. Carew, Ranadip Pal, Victor M. Rivera, Philippe Soriano, Brian J. Druker, Brian P. Rubin, Charles Keller
TYK2-STAT1-BCL2 Pathway Dependence in T-Cell Acute Lymphoblastic Leukemia. Cancer Discovery. Takaomi Sanda, Jeffrey W. Tyner, Alejandro Gutierrez, Vu N. Ngo, Jason Glover, Bill H. Chang, Arla Yost, Wenxue Ma, Angela G. Fleischman, Wenjun Zhou Yandan Yang, Maria Kleppe, Yebin Ahn, Jessica Tatarek, Michelle A. Kelliher, Donna S. Neuberg, Ross Levine, Richard Moriggl, Mathias Muller, Nathanael S. Gray, Catriona H. M. Jamieson, Andrew Weng, Louis M. Staudt, Brian J. Druker, and A. Thomas Look
Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening. Cancer Research. Jeffrey W. Tyner, Wayne F. Yang, Armand Bankhead III, Guang Fan, Luke B. Fletcher, Jade Bryant, Jason M. Glover, Bill H. Chang, Stephen E. Spurgeon, William H. Fleming, Tibor Kovacsovics, Jason R. Gotlib, Stephen T. Oh, Michael W. Deininger, Christian Michel Zwaan, Monique L. Den Boer, Marry M. van den Heuvel-Eibrink, Thomas O’Hare, Brian J. Druker,Marc M. Loriaux
